315 related articles for article (PubMed ID: 25384570)
1. Outcomes of androgen replacement therapy in adult male hypogonadism: recommendations from the Italian society of endocrinology.
Isidori AM; Balercia G; Calogero AE; Corona G; Ferlin A; Francavilla S; Santi D; Maggi M
J Endocrinol Invest; 2015 Jan; 38(1):103-12. PubMed ID: 25384570
[TBL] [Abstract][Full Text] [Related]
2. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin S; Brito JP; Cunningham GR; Hayes FJ; Hodis HN; Matsumoto AM; Snyder PJ; Swerdloff RS; Wu FC; Yialamas MA
J Clin Endocrinol Metab; 2018 May; 103(5):1715-1744. PubMed ID: 29562364
[TBL] [Abstract][Full Text] [Related]
3. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE).
Isidori AM; Aversa A; Calogero A; Ferlin A; Francavilla S; Lanfranco F; Pivonello R; Rochira V; Corona G; Maggi M
J Endocrinol Invest; 2022 Dec; 45(12):2385-2403. PubMed ID: 36018454
[TBL] [Abstract][Full Text] [Related]
4. Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline.
Wierman ME; Arlt W; Basson R; Davis SR; Miller KK; Murad MH; Rosner W; Santoro N
J Clin Endocrinol Metab; 2014 Oct; 99(10):3489-510. PubMed ID: 25279570
[TBL] [Abstract][Full Text] [Related]
5. Critical Update of the 2010 Endocrine Society Clinical Practice Guidelines for Male Hypogonadism: A Systematic Analysis.
Seftel AD; Kathrins M; Niederberger C
Mayo Clin Proc; 2015 Aug; 90(8):1104-15. PubMed ID: 26205546
[TBL] [Abstract][Full Text] [Related]
6. Testosterone treatment in the aging male: myth or reality?
Nigro N; Christ-Crain M
Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
[TBL] [Abstract][Full Text] [Related]
7. Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry.
Rastrelli G; Giovannini L; Calogero AE; Gianfrilli D; Serra E; Pizzocaro A; Giagulli VA; Motta G; Vancieri G; Sperandio A; Andò S; Selice R; Luca G; Cocchiara F; Canale D; Maggi M
J Endocrinol Invest; 2016 Jun; 39(6):695-708. PubMed ID: 27037688
[TBL] [Abstract][Full Text] [Related]
8. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.
Bhasin S; Cunningham GR; Hayes FJ; Matsumoto AM; Snyder PJ; Swerdloff RS; Montori VM;
J Clin Endocrinol Metab; 2010 Jun; 95(6):2536-59. PubMed ID: 20525905
[TBL] [Abstract][Full Text] [Related]
9. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
[TBL] [Abstract][Full Text] [Related]
10. Critical evaluation of different available guidelines for late-onset hypogonadism.
Giagulli VA; Castellana M; Lisco G; Triggiani V
Andrology; 2020 Nov; 8(6):1628-1641. PubMed ID: 32593233
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).
Khera M; Adaikan G; Buvat J; Carrier S; El-Meliegy A; Hatzimouratidis K; McCullough A; Morgentaler A; Torres LO; Salonia A
J Sex Med; 2016 Dec; 13(12):1787-1804. PubMed ID: 27914560
[TBL] [Abstract][Full Text] [Related]
12. Canadian Society for the Study of the Aging Male: response to health Canada's position paper on testosterone treatment.
Bain J; Brock G; Kuzmarov I; For The International Consulting Group
J Sex Med; 2007 May; 4(3):558-566. PubMed ID: 17498097
[TBL] [Abstract][Full Text] [Related]
13. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
Traish AM
Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
[TBL] [Abstract][Full Text] [Related]
14. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
15. MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
Lapauw B; Kaufman JM
Eur J Endocrinol; 2020 Dec; 183(6):R167-R183. PubMed ID: 33105105
[TBL] [Abstract][Full Text] [Related]
16. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
[TBL] [Abstract][Full Text] [Related]
17. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
[TBL] [Abstract][Full Text] [Related]
18. Current topics in testosterone replacement of hypogonadal men.
Nieschlag E
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):77-90. PubMed ID: 25617174
[TBL] [Abstract][Full Text] [Related]
19. Androgen replacement in men with hypogonadism and erectile dysfunction.
Albrecht-Betancourt M; Hijazi RA; Cunningham GR
Endocrine; 2004; 23(2-3):143-8. PubMed ID: 15146093
[TBL] [Abstract][Full Text] [Related]
20. Commentary: Guideline for male testosterone therapy: a regulatory perspective.
Shames D; Gassman A; Handelsman H
J Clin Endocrinol Metab; 2007 Feb; 92(2):414-5. PubMed ID: 17284641
[No Abstract] [Full Text] [Related]
[Next] [New Search]
